Fluor bags award for Biologics manufacturing facility in Scandinavia

Construction is now underway with the facility scheduled to be operational by 2025

Matt Sause elevated as new CEO of Roche Diagnostics

Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.

Sumitovant Biopharma and Sumitomo Pharma to acquire outstanding shares of Myovant Sciences

The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.

Piramal Pharma appoints Vibha Paul Rishi as Non- Executive Director

Dr VK Paul delivers lecture at NITI Aayog’s First India Development Strategies Lecture Series

Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic

Indian medical devices industry to grow at 28% annually to reach US$ 50 bn by 2030: Health Minister

Department and Industry Associations to organize 3 days National Level Expo on Indian Medical Devices Sector at Pragati Maidan, New Delhi between 9-11 Dec 2022, first of its kind expo in India

Philips shareholders appoint Roy Jakobs as next President and CEO

Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally

USFDA inspects Zydus Lifesciences Ahmedabad SEZ facility

The company will address the observations within a stipulated timeline working with the regulators

Lupin receives warning letter from US FDA

The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility

Lupin receives US FDA approval for Mirabegron Extended-Release tablets

Mirabegron Extended-Release Tablets, 25 mg and 50 mg, had estimated annual sales of US $2.4 billion in US